ID
36085
Description
Study ID: 101468/201 Clinical Study ID: 101468/201 Study Title: A Single Blind, Parallel Group, Up-titration, Phase 1 Study in Healthy Volunteers to Determine a Starting Dose and Select an Up-titration Regimen for a new Formulation of Ropinirole Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of 21 Visits(Days): Screening (Day 0) Week 1: including Day 1-7 Week 2: including Day 8-14 Week 3: including Day 15-19 Follow-up Visit (Day 21) This document contains the prior medication form. It has to be filled in for screening.
Mots-clés
Versions (3)
- 15/04/2019 15/04/2019 -
- 15/04/2019 15/04/2019 -
- 20/09/2021 20/09/2021 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
15 avril 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Determination of starting dose and up-titration regimen for a new formulation of Ropinirole, 101468/201
Prior Medication
- StudyEvent: ODM
Description
Prior Medication
Alias
- UMLS CUI-1
- C2826257 (Prior Medication Usage)
Description
If 'YES', please record the medications below.
Type de données
boolean
Alias
- UMLS CUI [1]
- C3166216 (Prescribed medications)
- LOINC
- LP124834-5
- UMLS CUI [2]
- C0013231 (Drugs, Non-Prescription)
Description
(Trade Name Preferred)
Type de données
text
Alias
- UMLS CUI [1]
- C2360065 (Medication name)
- LOINC
- MTHU027854
Description
Single Dose/Unit
Type de données
text
Alias
- UMLS CUI [1]
- C1960417 (Single dose characteristic)
- SNOMED
- 426146003
Description
Frequency of this Dose
Type de données
text
Alias
- UMLS CUI [1]
- C3476109 (Medication frequency)
- LOINC
- LP149758-7
Description
Route
Type de données
text
Alias
- UMLS CUI [1]
- C0013153 (Drug Administration Routes)
- SNOMED
- 410675002
- LOINC
- LP40261-7
Description
Indication
Type de données
text
Alias
- UMLS CUI [1,1]
- C3146298 (Indication)
- UMLS CUI [1,2]
- C0013227 (Pharmaceutical Preparations)
- SNOMED
- 763158003
- LOINC
- LP100609-9
Description
Duration of therapy
Type de données
text
Alias
- UMLS CUI [1]
- C0444917 (undefined)
Description
Day/Month/Year
Type de données
date
Alias
- UMLS CUI [1,1]
- C0013227 (Pharmaceutical Preparations)
- SNOMED
- 763158003
- LOINC
- LP100609-9
- UMLS CUI [1,2]
- C0806020 (End date)
- SNOMED
- 454551000124105
- LOINC
- MTHU008302
Description
Continuing at end of study
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C1553904 (continuing therapy)
- UMLS CUI [1,2]
- C2983670 (Study End Date)
Similar models
Prior Medication
- StudyEvent: ODM
C0013231 (UMLS CUI [2])
C0013227 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C2983670 (UMLS CUI [1,2])
Aucun commentaire